Dylan Yowell, 13-year old from El Dorado, Ark., and his mother Jackie Fuller are the focus of the newest billboard campaign by LifeShare Blood Centers. A real-life patient story, Dylan was diagnosed with Acute Lymphoblastic Leukemia one year ago resulting in intense treatment that includes blood products. The billboards display a candid photo of Dylan and his mother with the caption, “Change A Future.” Dylan is currently in maintenance chemotherapy.
“My husband has given blood as often as he could for years. Little did we know how much that would mean to our family and how it could impact others. Thank God for blood donors who understand the need and give regularly. Because of them, the blood was available for transfusion during Dylan’s time of need,” says Fuller.
LifeShare Blood Centers outdoor billboards will run in the LifeShare service area, which includes most of Louisiana and reaches into East Texas and South Arkansas. “The billboards serve as a reminder to residents that giving blood is a community responsibility. Because LifeShare is the primary blood provider to medical facilities in the areas where the blood is donated, it goes right back to save the lives of family, friends and neighbors. Dylan is one of the many residents in which blood donation has made a life-saving difference,” says Tina Martinez, Communications Director for LifeShare Blood Centers.
The outdoor billboard creative was developed by Suzanne Smith Upchurch, Marketing Director for LifeShare Blood Centers. The billboards are expected to remain or rotate at least through July 2012, one of which is now visible on LA3132 at Linwood Ave. in Shreveport, La. next to LifeShare Blood Centers’ headquarters.
LifeShare Blood Centers regularly supplies blood components to 117 medical facilities throughout Louisiana, East Texas and South Arkansas. Founded in Shreveport, La. in 1942, it is a nonprofit community service provider governed by a volunteer Board of Trustees. LifeShare is a member of America’s Blood Centers and the American Rare Donor Program, is licensed by the U.S. Food & Drug Administration and accredited by AABB.